HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Per Bo Jensen Selected Research

ragaglitazar

9/2003Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
3/2003PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Per Bo Jensen Research Topics

Disease

2Insulin Resistance
09/2003 - 03/2003
1Oncogene Addiction
04/2013
1Neoplasms (Cancer)
04/2013
1Insulinoma
05/2005
1Obesity
09/2003
1Fatty Liver
03/2003
1Hepatomegaly
03/2003
1Body Weight (Weight, Body)
04/2002

Drug/Important Bio-Agent (IBA)

2ragaglitazarIBA
09/2003 - 03/2003
2PPAR alphaIBA
09/2003 - 03/2003
1Phosphotransferases (Kinase)IBA
04/2013
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
04/2013
1Glucose (Dextrose)FDA LinkGeneric
05/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2003
1PPAR-gamma AgonistsIBA
09/2003
1Fenofibrate (CiL)FDA LinkGeneric
09/2003
1Pioglitazone (Actos)FDA Link
09/2003
1pirinixic acidIBA
03/2003
1Insulin (Novolin)FDA Link
03/2003
1Triglycerides (Triacylglycerol)IBA
03/2003
1Peptides (Polypeptides)IBA
04/2002
1Cocaine (Cocaine HCl)IBA
04/2002
1Proglucagon (Glucagon Precursors)IBA
04/2002
1Amphetamine (Amfetamine)FDA LinkGeneric
04/2002
1NeuropeptidesIBA
04/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
04/2002